LeonaBio Financial Statements From 2010 to 2026

LONA Stock   4.72  0.07  1.51%   
LeonaBio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing LeonaBio's valuation are provided below:
We have found one hundred fifteen available fundamental ratios for LeonaBio, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of LeonaBio last-minute market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. As of February 5, 2026, Market Cap is expected to decline to about 24.7 M. The current year's Enterprise Value is expected to grow to about (26.9 M)
Check LeonaBio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LeonaBio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 945.8 K, Interest Expense of 29.4 M or Selling General Administrative of 19.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.48. LeonaBio financial statements analysis is a perfect complement when working with LeonaBio Valuation or Volatility modules.
  
Build AI portfolio with LeonaBio Stock
Check out the analysis of LeonaBio Correlation against competitors.
For information on how to trade LeonaBio Stock refer to our How to Trade LeonaBio Stock guide.

LeonaBio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets64.2 M67.6 M74.5 M
Slightly volatile
Short and Long Term Debt Total1.6 M1.4 M1.1 M
Slightly volatile
Other Current Liabilities11.3 M14.3 MM
Slightly volatile
Total Current Liabilities12.4 M15.1 M6.5 M
Slightly volatile
Accounts Payable348.5 K366.9 K405.8 K
Slightly volatile
Cash64.7 M55.7 M32.8 M
Slightly volatile
Non Current Assets Total3.4 M3.5 M13.3 M
Slightly volatile
Cash And Short Term Investments56 M59 M58.7 M
Slightly volatile
Net Receivables1.2 M1.9 M661.4 K
Slightly volatile
Common Stock Shares Outstanding3.9 M4.4 M3.5 M
Slightly volatile
Short Term Investments2.4 M2.6 M33.8 M
Slightly volatile
Liabilities And Stockholders Equity64.2 M67.6 M74.5 M
Slightly volatile
Non Current Liabilities Total686.6 K722.7 K11.8 M
Slightly volatile
Other Current Assets4.3 M4.1 M2.2 M
Slightly volatile
Other Stockholder Equity322.8 M518.6 M170.8 M
Slightly volatile
Total Liabilities19.6 M16 M18.8 M
Pretty Stable
Total Current Assets59.9 M63.1 M61.1 M
Slightly volatile
Common StockK4.6 K3.4 K
Slightly volatile
Non Currrent Assets Other60.1 K63.2 K92.9 K
Slightly volatile
Property Plant And Equipment Net3.5 M2.9 M3.8 M
Pretty Stable
Short Term Debt334.4 K476.1 K210 K
Slightly volatile
Capital Lease Obligations1.3 M1.1 M1.8 M
Slightly volatile
Net Invested Capital38.3 M40.4 M255.4 M
Slightly volatile
Property Plant And Equipment Gross7.1 M7.5 M6.1 M
Slightly volatile
Capital Stock3.2 K3.6 K3.9 K
Slightly volatile
Net Working Capital35.7 M37.5 M202.6 M
Slightly volatile

LeonaBio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization945.8 K873 KM
Slightly volatile
Interest Expense29.4 M28 M7.7 M
Slightly volatile
Selling General Administrative19.3 M30 M10.8 M
Slightly volatile
Other Operating Expenses66.6 M116 M38.1 M
Slightly volatile
Research Development45.5 M81.3 M26.2 M
Slightly volatile
Total Operating Expenses66.3 M116 M37.9 M
Slightly volatile
Cost Of Revenue409.5 K431.1 K1.5 M
Slightly volatile
Net Interest Income267.2 K300.6 K328.1 K
Slightly volatile
Interest Income269.6 K303.3 K331.1 K
Slightly volatile
Reconciled Depreciation897.3 K1.1 M620.3 K
Slightly volatile

LeonaBio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation13.3 M12.7 M3.9 M
Slightly volatile
Begin Period Cash Flow57.9 M104.9 M33.3 M
Slightly volatile
Other Cashflows From Financing Activities357.2 K376.1 K9.9 M
Pretty Stable
Total Cash From Financing Activities165.9 K174.6 K23.9 M
Pretty Stable
End Period Cash Flow64.9 M56.4 M33 M
Slightly volatile
Other Cashflows From Investing Activities43.5 K41.4 K19.6 K
Slightly volatile
Change To InventoryK1.2 K1.3 K
Slightly volatile
Depreciation704.4 K523.2 K408.2 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.07920.08346.2703
Slightly volatile
Payables Turnover1.420.971.4569
Slightly volatile
Cash Per Share11.3911.9915.7691
Slightly volatile
Days Payables Outstanding257389276
Slightly volatile
Income Quality0.710.90.8739
Very volatile
Net Debt To EBITDA0.540.5717.8916
Slightly volatile
Current Ratio4.564.810.5331
Very volatile
Capex Per Share0.00940.00990.5113
Slightly volatile
Interest Debt Per Share0.270.280.6926
Pretty Stable
Debt To Assets0.02260.02380.1247
Slightly volatile
Days Of Payables Outstanding257389276
Slightly volatile
Ebt Per Ebit1.051.10.9958
Pretty Stable
Quick Ratio4.564.810.5364
Very volatile
Cash Ratio6.974.245.9989
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.131.151.082
Pretty Stable
Debt Ratio0.02260.02380.1247
Slightly volatile

LeonaBio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap24.7 M26 M401.7 M
Slightly volatile

LeonaBio Fundamental Market Drivers

About LeonaBio Financial Statements

LeonaBio stakeholders use historical fundamental indicators, such as LeonaBio's revenue or net income, to determine how well the company is positioned to perform in the future. Although LeonaBio investors may analyze each financial statement separately, they are all interrelated. For example, changes in LeonaBio's assets and liabilities are reflected in the revenues and expenses on LeonaBio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in LeonaBio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue431.1 K409.5 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether LeonaBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of LeonaBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Leonabio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Leonabio Stock:
Check out the analysis of LeonaBio Correlation against competitors.
For information on how to trade LeonaBio Stock refer to our How to Trade LeonaBio Stock guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LeonaBio. Expected growth trajectory for LeonaBio significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive LeonaBio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding LeonaBio requires distinguishing between market price and book value, where the latter reflects LeonaBio's accounting equity. The concept of intrinsic value - what LeonaBio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push LeonaBio's price substantially above or below its fundamental value.
Understanding that LeonaBio's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LeonaBio represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, LeonaBio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.